Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Bad
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Bad
|
New words:
abstract, algorithm, American, anticancer, appointed, asco, assigning, billion, chance, Chicago, choice, clear, confirm, confirmed, DDT, disappear, diversity, Dr, driven, evidence, expansion, Eyal, Gail, group, issuer, ITT, LI, Link, LR, meaningful, meant, medical, MM, Naughton, objective, pathology, portion, poster, pretreatment, prospectively, published, Society, Talor, trustee, tumor, unmet, written
Removed:
annually, July, magnitude, patient, proved, receiving, remained, stated, worldwide
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view